Literature DB >> 2053595

X-linked lymphoreticular disease in the scurfy (sf) mutant mouse.

V L Godfrey1, J E Wilkinson, L B Russell.   

Abstract

Scurfy (sf) is a spontaneous, sex-linked, recessive mutation that maps to the extreme proximal portion of the X chromosome, about 2 centimorgans from sparse fur (spf). Hemizygotes for sf manifest several clinical disorders, evident at 14 days of age, including scaliness and crusting of the eyelids, ears, and tail, runting, reddening and swelling of the genital papilla, anemia, cachexia, and early death (average, 24 days). Our studies indicate that the phenotype of hemizygous scurfy is not, as has been suggested, a model for human X-linked ichthyosis, but appears to be a disease primarily affecting the lymphoreticular, and possibly the hematopoietic, systems. Gross lesions include marked splenomegaly, hepatomegaly, enlarged lymph nodes, and variable thickening of the ears. The characteristic histologic lesion is a lymphohistiocytic proliferation and infiltration of peripheral lymph nodes, spleen, liver, and skin. In routine hematoxylin and eosin-stained sections, these lesions efface lymph node architecture, thicken the dermis, and form nodular portal infiltrates in the liver. Scurfy lesions characteristically contain a population of large blastlike cells with round to oval nuclei, a vesicular chromatin pattern, and prominent single nucleoli. Mixed perivascular infiltrates of lymphocytes, macrophages, and granulocytes sometimes are found in kidney, heart, pancreas, lung, and mesenteries. There is excessive hematopoiesis in the liver and spleen. Cells expressing B220 or Thy-1 antigens localize to appropriate areas in the lymph nodes and spleen, but are rare in the portal infiltrates and are absent from the skin. There is a marked, polyclonal increase in serum IgG, severe Coombs'-positive anemia, and leukocytosis with atypical mononuclear cells. Scurfy mice are negative for antinuclear antibodies. Despite their morphologically aberrant lymphoreticular system, scurfy mice can exist in a conventional environment without evidence of opportunistic infection. Raising scurfy mice in a specific-pathogen-free environment does not alter disease expression. Thus, while our findings indicate that scurfy disease may be the result of immune dysfunction, it is not a classic immunodeficiency.

Entities:  

Mesh:

Year:  1991        PMID: 2053595      PMCID: PMC1886400     

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  7 in total

1.  THE Y-CHROMOSOME AS THE BEARER OF MALE DETERMINING FACTORS IN THE MOUSE.

Authors:  W J Welshons; L B Russell
Journal:  Proc Natl Acad Sci U S A       Date:  1959-04       Impact factor: 11.205

2.  EXCEPTIONAL INHERITANCE OF A SEX-LINKED GENE IN THE MOUSE EXPLAINED ON THE BASIS THAT THE X/O SEX-CHROMOSOME CONSTITUTION IS FEMALE.

Authors:  W L Russell; L B Russell; J S Gower
Journal:  Proc Natl Acad Sci U S A       Date:  1959-04       Impact factor: 11.205

Review 3.  The William Allan memorial award address: X-chromosome inactivation and the location and expression of X-linked genes.

Authors:  M F Lyon
Journal:  Am J Hum Genet       Date:  1988-01       Impact factor: 11.025

4.  X-linked ichthyosis due to steroid-sulphatase deficiency.

Authors:  D Webster; J T France; L J Shapiro; R Weiss
Journal:  Lancet       Date:  1978-01-14       Impact factor: 79.321

5.  Induction of dermal and subcutaneous inflammation by recombinant cachectin/tumor necrosis factor (TNF alpha) in the mouse.

Authors:  R J Sharpe; R J Margolis; M Askari; E P Amento; R D Granstein
Journal:  J Invest Dermatol       Date:  1988-10       Impact factor: 8.551

6.  Tumors secreting human TNF/cachectin induce cachexia in mice.

Authors:  A Oliff; D Defeo-Jones; M Boyer; D Martinez; D Kiefer; G Vuocolo; A Wolfe; S H Socher
Journal:  Cell       Date:  1987-08-14       Impact factor: 41.582

7.  Immunomodulatory properties of recombinant murine and human tumor necrosis factor.

Authors:  J E Talmadge; H Phillips; M Schneider; T Rowe; R Pennington; O Bowersox; B Lenz
Journal:  Cancer Res       Date:  1988-02-01       Impact factor: 12.701

  7 in total
  135 in total

1.  Prospective immunological profiling in a case of immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome (IPEX).

Authors:  A C Bakke; M Z Purtzer; R S Wildin
Journal:  Clin Exp Immunol       Date:  2004-08       Impact factor: 4.330

2.  Cell-autonomous role of TGFβ and IL-2 receptors in CD4+ and CD8+ inducible regulatory T-cell generation during GVHD.

Authors:  Norifumi Sawamukai; Atsushi Satake; Amanda M Schmidt; Ian T Lamborn; Priti Ojha; Yoshiya Tanaka; Taku Kambayashi
Journal:  Blood       Date:  2012-04-10       Impact factor: 22.113

3.  Novel role of regulatory T cells in limiting early neutrophil responses in skin.

Authors:  Hannah Richards; Anwen Williams; Emma Jones; James Hindley; Andrew Godkin; Anna Katharina Simon; Awen Gallimore
Journal:  Immunology       Date:  2010-08-17       Impact factor: 7.397

4.  Escape from tolerance in the human X-linked autoimmunity-allergic disregulation syndrome and the Scurfy mouse.

Authors:  D D Patel
Journal:  J Clin Invest       Date:  2001-01       Impact factor: 14.808

Review 5.  Phosphatidylinositol 3 Kinase δ Inhibitors: Present and Future.

Authors:  Jennifer R Brown
Journal:  Cancer J       Date:  2019 Nov/Dec       Impact factor: 3.360

Review 6.  Clinical and molecular features of the immunodysregulation, polyendocrinopathy, enteropathy, X linked (IPEX) syndrome.

Authors:  R S Wildin; S Smyk-Pearson; A H Filipovich
Journal:  J Med Genet       Date:  2002-08       Impact factor: 6.318

7.  Regulatory T cell expansion and immune activation during untreated HIV type 1 infection are associated with disease progression.

Authors:  Weiwei Cao; Beth D Jamieson; Lance E Hultin; Patricia M Hultin; Roger Detels
Journal:  AIDS Res Hum Retroviruses       Date:  2009-02       Impact factor: 2.205

8.  BRG1-mediated immune tolerance: facilitation of Treg activation and partial independence of chromatin remodelling.

Authors:  Barbara H Chaiyachati; Anant Jani; Yisong Wan; Haichang Huang; Richard Flavell; Tian Chi
Journal:  EMBO J       Date:  2013-01-15       Impact factor: 11.598

Review 9.  Function of tumor necrosis factor receptor family members on regulatory T-cells.

Authors:  Robert H Arch
Journal:  Immunol Res       Date:  2005       Impact factor: 2.829

10.  CD4+CD25+Foxp3+ Tregs resolve experimental lung injury in mice and are present in humans with acute lung injury.

Authors:  Franco R D'Alessio; Kenji Tsushima; Neil R Aggarwal; Erin E West; Matthew H Willett; Martin F Britos; Matthew R Pipeling; Roy G Brower; Rubin M Tuder; John F McDyer; Landon S King
Journal:  J Clin Invest       Date:  2009-09-21       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.